Amanote Research
Register
Sign In
2',5'-Oligoadenylate Synthetase Levels in Patients With Multiple Myeloma Receiving Maintenance Therapy With Interferon Alpha 2b Do Not Correlate With Clinical Response
British Journal of Cancer
- United Kingdom
doi 10.1038/bjc.1995.541
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
December 1, 1995
Authors
BC Millar
JBG Bell
Publisher
Springer Science and Business Media LLC
Related search
Lymphocyte Recovery and Clinical Response in Multiple Myeloma Patients Receiving Interferon Alpha 2 Beta After Intensive Therapy
British Journal of Cancer
Cancer Research
Oncology
Indacaterol Therapy in Patients With COPD Not Receiving Other Maintenance Treatment
Respiratory Medicine
Pulmonary
Respiratory Medicine
Signal Transduction Pathways in the Induction of 2',5'-Oligoadenylate Synthetase Gene Expression by Interferon Alpha/Beta.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
PHARMACOKINETIC STUDY OF a HUMAN RECOMBINANT INTERFERON (Re-Ifn-^|^alpha;A) IN CYNOMOLGUS MONKEYS BY 2'-5' OLIGOADENYLATE SYNTHETASE ASSAY
Japanese Journal of Medical Science and Biology
Interferon Alpha-2b Therapy in Chronic Hepatitis Delta
Hepatitis Monthly
Hepatology
Infectious Diseases
Ribavirin Dosage in Patients With HCV Genotypes 2 and 3 Who Completed Short Therapy With Peg-Interferon Α-2b and Ribavirin
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
High Level Activity of 2', 5'-Oligoadenylate Synthetase in Dog Serum
Journal of Veterinary Medical Science
Veterinary
Immune Interferon Inhibits Proliferation and Induces 2'-5'-Oligoadenylate Synthetase Gene Expression in Human Vascular Smooth Muscle Cells.
Journal of Clinical Investigation
Medicine
Response to Salvage Therapies and Outcome in Patients With Multiple Myeloma Relapsing After Pomalidomide Therapy
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
